{"id":"placebo-for-terbutaline-sulphate","safety":{"commonSideEffects":[{"rate":null,"effect":"No adverse events"}]},"_chembl":{"chemblId":"CHEMBL1315867","moleculeType":"Small molecule","molecularWeight":"548.66"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease.","oneSentence":"Placebo does not have a pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:22.361Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of asthma symptoms"}]},"trialDetails":[{"nctId":"NCT05326269","phase":"NA","title":"Acute Tocolysis With Terbutaline for Suspected Fetal Distress","status":"COMPLETED","sponsor":"Hospital Kemaman","startDate":"2017-04-23","conditions":"Nonreassuring Fetal Status","enrollment":100},{"nctId":"NCT02224157","phase":"PHASE3","title":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11-28","conditions":"Asthma","enrollment":4215},{"nctId":"NCT02149199","phase":"PHASE3","title":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-07-07","conditions":"Asthma","enrollment":3850},{"nctId":"NCT01582646","phase":"PHASE2","title":"Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2012-01","conditions":"Postthoracotomy Pain, Postthoracoscopy Neuropathic Pain","enrollment":20},{"nctId":"NCT02322788","phase":"PHASE3","title":"Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-03","conditions":"Asthma","enrollment":95},{"nctId":"NCT01651962","phase":"PHASE4","title":"Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement","status":"UNKNOWN","sponsor":"Kai Schoenhage","startDate":"2012-08","conditions":"Labor Pain","enrollment":250},{"nctId":"NCT00849095","phase":"PHASE3","title":"Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma","status":"COMPLETED","sponsor":"Università degli Studi di Ferrara","startDate":"2009-04","conditions":"Asthma","enrollment":860}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":22,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo powder for inhalation"],"phase":"phase_3","status":"active","brandName":"Placebo for terbutaline sulphate","genericName":"Placebo for terbutaline sulphate","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo does not have a pharmacological effect. Used for Treatment of asthma symptoms.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}